Literature DB >> 18773629

Changes of clinical features in hydatidiform mole: analysis of 113 cases.

Jin-Lin Hou1, Xi-Run Wan, Yang Xiang, Qing-Wei Qi, Xiu-Yu Yang.   

Abstract

OBJECTIVE: To investigate the changes of the clinical features of hydatidiform mole. STUDY
DESIGN: A total of 113 cases of hydatidiform mole treated in Peking Union Medical College Hospital during 1989-2006 were reviewed retrospectively, and a comparison was made to historic data from 1948-1975 using the chi2 test.
RESULTS: The median age was 28 years (range, 20-55). The median gestational age was 90.2 days. Vaginal bleeding remains the most common presenting symptom, occurring in 94 of 113 cases (83.2%). Of 113 cases, 52 (46%) presented with excessive uterine size. Preeclampsia, hyperemesis, hemoptysis and theca lutein cysts occurred in 4 of 113 (3.5%), 12 of 113 (10.6%), 4 of 113 (3.5%) and 19 of 113 cases (16.8%), respectively. The incidence of postmolar trophoblastic neoplasia was 21% (24 of 113). Compared to historic data, the incidence of vaginal bleeding and preeclampsia were statistically lower (p < 0.005). The incidence of postmolar gestational trophoblastic neoplasia was increased moderately without statistical significance compared to historic data.
CONCLUSION: Because of the wide use of ultrasonography and serum human chorionic gonadotropin test, current patients with hydatidiform mole have been diagnosed earlier in gestation and the clinical features have changed. Patterns of medical practice should be changed as well.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773629

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  10 in total

Review 1.  Gestational trophoblastic tumours: an update for 2014.

Authors:  Fieke E M Froeling; Michael J Seckl
Journal:  Curr Oncol Rep       Date:  2014-11       Impact factor: 5.075

Review 2.  First-trimester emergencies: a radiologist's perspective.

Authors:  Catherine H Phillips; Jeremy R Wortman; Elizabeth S Ginsburg; Aaron D Sodickson; Peter M Doubilet; Bharti Khurana
Journal:  Emerg Radiol       Date:  2017-09-25

3.  Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta.

Authors:  Mauro Parra-Cordero; Cleofina Bosco; Jaime González; Rodrigo Gutiérrez; Pilar Barja; Ramón Rodrigo
Journal:  J Mol Histol       Date:  2011-08-17       Impact factor: 2.611

Review 4.  Gestational Trophoblastic Disorders: An Update in 2015.

Authors:  F T Stevens; N Katzorke; C Tempfer; U Kreimer; G I Bizjak; M C Fleisch; T N Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

5.  Incidence, management, and outcome of molar pregnancies at a tertiary care hospital in quetta, pakistan.

Authors:  Mahrukh Fatima; Pashtoon Murtaza Kasi; Shahnaz Naseer Baloch; Masoom Kassi; Shah Muhammad Marri; Mahwash Kassi
Journal:  ISRN Obstet Gynecol       Date:  2011-10-16

6.  Hydatidiform mole in Jos, Nigeria.

Authors:  Amaka N Ocheke; Jonah Musa; Alexander O Uamai
Journal:  Niger Med J       Date:  2011-10

7.  A 34-Week Size Uterus with a Complete Hydatidiform Mole: Hook Effect and Severe Anemia with No Vaginal Bleeding.

Authors:  Rodney McLaren; Vijaya Bayya; Mohamad Irani
Journal:  Case Rep Obstet Gynecol       Date:  2018-02-13

8.  Educational Case: Hydatidiform Molar Pregnancy.

Authors:  Anna Lepore; Richard M Conran
Journal:  Acad Pathol       Date:  2021-01-28

9.  Incidence and outcome of gestational trophoblastic disease in lower Egypt.

Authors:  Ahmed Zakaria; Reda Hemida; Waleed Elrefaie; Ehsan Refaie
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

10.  Readmissions due to hyperemesis gravidarum: a nation-wide Finnish register study.

Authors:  Miina Nurmi; Päivi Rautava; Mika Gissler; Tero Vahlberg; Päivi Polo-Kantola
Journal:  Arch Gynecol Obstet       Date:  2022-02-28       Impact factor: 2.493

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.